BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Dec. 30, 2003
View Archived Issues
Trudeaux Scientists Find Old Age Impacts Longest-Term Efficiency; Youngest Vaccines Do Best Work
Read More
Arena Raises $35M Through Sale Of Preferred Convertible Shares
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Pharmion Files NDA On Vidaza For Myelodysplastic Syndromes
Pharmion Corp. filed a new drug application seeking approval to market Vidaza, an orphan-designated product, as a treatment for myelodysplastic syndromes. (BioWorld Today)
Read More
Memory Pharma, Santarus File As IPO Hopefuls Line Runway
Read More